Blood-based biomarker analysis in high PD-L1 expressing NSCLC treated with PD-1/PD-L1 based therapy with or without the addition of platinum-based chemotherapy von Fidler, Mary J., Villaflor, Victoria Meucci, Rao, Amol, Halmos, Balazs, Bertino, Erin Marie, Osarogiagbon, Raymond U., Carbone, David Paul

Volltext

Circulating tumor DNA (ctDNA) in HER2 exon 20 insertion mutations and responses in NSCLC HER2 exon 20 insertion treated with poziotinib von Thiagalingam, Arunthi, Lakshmikanthan, Sribalaji, Mak, Allysia, Shell, Scott A., Leu, Sharon, Sun, Sophie, Bertino, Erin Marie, Haura, Eric B., Washington, Rocky, Bhat, Gajanan, Lebel, Francois M., Barrett, John A.

Volltext

Immune checkpoint inhibitor-related thrombocytopenia: Incidence, risk factors, and effect on overall survival von Haddad, Tyler, Zhao, Songzhu, Li, Mingjia, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Lopez, Gabrielle, Miah, Abdul, Wei, Lai, Tinoco, Gabriel, Riesenberg, Brian P, Li, Zihai, Bertino, Erin Marie, Kendra, Kari Lynn, Otterson, Gregory Alan, Presley, Carolyn J, Owen, Dwight Hall

Volltext

Bone modifying agents and skeletal related events in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors von Das, Parthib, Zhao, Songzhu, Wei, Lai, Miah, Abdul, Li, Mingjia, Lopez, Gabrielle, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Bertino, Erin Marie, He, Kai, Shields, Peter G., Carbone, David Paul, Otterson, Gregory Alan, Presley, Carolyn J, Owen, Dwight Hall

Volltext

Initiation of targeted therapy based on ctDNA only in metastatic NSCLC von Bustamante Alvarez, Jean Gabriel, Dittmar, Kristin, Janse, Sarah A, Kiourtsis, Stephanie, Owen, Dwight Hall, Bertino, Erin Marie, He, Kai, Carbone, David Paul, Otterson, Gregory Alan

Volltext

Neutrophil-lymphocyte score: A novel prognostic scoring system that utilized the dynamic change of neutrophil, lymphocyte, and albumin and its comparison to other indices von Zhao, Songzhu, Li, Mingjia, Spakowicz, Daniel, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Miah, Abdul, Husain, Marium, He, Kai, Bertino, Erin Marie, Shields, Peter G., Wei, Lai, Carbone, David Paul, Otterson, Gregory Alan, Presley, Carolyn J, Owen, Dwight Hall

Volltext

Inhaled corticosteroid use and risk of pneumonitis in patients treated with immune checkpoint inhibitors von Li, Mingjia, Spakowicz, Daniel, Zhao, Songzhu, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Miah, Abdul, Husain, Marium, He, Kai, Bertino, Erin Marie, Shields, Peter G., Wei, Lai, Carbone, David Paul, Otterson, Gregory Alan, Presley, Carolyn J, Owen, Dwight Hall

Volltext

Neutrophil to lymphocyte ratio, PD-L1 expression, and survival in patients with advanced non-small cell lung cancer receiving first-line immune checkpoint inhibitor therapy von Li, Mingjia, Zhao, Songzhu, Spakowicz, Daniel, Burkart, Jarred Thomas, Patel, Sandip H., Husain, Marium, He, Kai, Bertino, Erin Marie, Shields, Peter G., Wei, Lai, Presley, Carolyn J, Otterson, Gregory Alan, Owen, Dwight Hall

Volltext

Second cancer incidence in CLL patients receiving BTK inhibitors von Bond, David Alan, Huang, Ying, Fisher, James L, Ruppert, Amy S., Owen, Dwight Hall, Bertino, Erin Marie, Rogers, Kerry Anne, Bhat, Seema Ali, Jaglowski, Samantha Mary, Grever, Michael R., Byrd, John C., Maddocks, Kami J., Woyach, Jennifer Ann

Volltext

Platelets impact the responsiveness of immune checkpoint blockade therapy in solid tumors von Riesenberg, Brian P, Li, Mingjia, Spakowicz, Daniel, Hoyd, Rebecca, Beane, Joal, Yang, Yuanquan, Oezkan, Filiz, He, Kai, Patel, Sandip H., Johns, Andrew, Grogan, Madison, Miah, Abdul, Husain, Marium, Bertino, Erin Marie, Otterson, Gregory Alan, Kendra, Kari Lynn, Presley, Carolyn J, Carbone, David Paul, Li, Zihai, Owen, Dwight Hall

Volltext

Changes in lymphocyte/monocyte ratio, prognostic marker to predict overall survival in patients with advanced cancer treated with immune checkpoint inhibitor von Patel, Sandip H., Li, Mingjia, Zhao, Songzhu, Wei, Lai, Burkart, Jarred Thomas, Husain, Marium, He, Kai, Bertino, Erin Marie, Shields, Peter G., Carbone, David Paul, Verschraegen, Claire F., Otterson, Gregory Alan, Kendra, Kari Lynn, Spakowicz, Daniel, Presley, Carolyn J, Owen, Dwight Hall

Volltext

Impact of immune-related adverse events (irAE) on overall survival (OS) in patients treated with immunotherapy for non-small cell lung cancer (NSCLC) von Owen, Dwight Hall, Wei, Lai, Villalona-Calero, Miguel Angel, Bertino, Erin Marie, He, Kai, Shields, Peter G., Carbone, David P., Otterson, Gregory Alan

Volltext

Re-evaluating the neutrophil-to-lymphocyte ratio: Machine learning-based variable selection for predicting survival at twelve months in late-stage cancer patients receiving immunot... von Spakowicz, Daniel, Li, Mingjia, Hoyd, Rebecca, Burkart, Jarred Thomas, Patel, Sandip H., Husain, Marium, He, Kai, Presley, Carolyn J, Bertino, Erin Marie, Shields, Peter G., Carbone, David Paul, Shah, Hiral A., Tinoco, Gabriel, Folefac, Edmund, Bhateja, Priyanka, Verschraegen, Claire F., Otterson, Gregory Alan, Li, Lang, Kendra, Kari Lynn, Owen, Dwight Hall

Volltext

Enhancement of cetuximab-induced antibody-dependent cellular cytotoxicity (ADCC) with lenalidomide in advanced solid tumors: A phase 1 trial von Bertino, Erin Marie, McMichael, Elizabeth L, Villalona-Calero, Miguel Angel, Grever, Michael R., Carson, William Edgar, Otterson, Gregory Alan

Volltext

Addition of HSP90 inhibitor onalespib to crizotinib prior to progression in patients with ALK-pos NSCLC: Results of a randomized phase 2 study von Lee, Jong-Seok, Han, Ji-Youn, Ahn, Myung-Ju, Oh, In-Jae, Kim, HyeRyun, Lee, Dae Ho, Bertino, Erin Marie, Viteri Ramirez, Santiago, Pennell, Nathan A., Wozniak, Antoinette J., Schiller, Joan H., Lin, Chester, Keer, Harold N., Azab, Mohammad, Besse, Benjamin, Camidge, D. Ross

Volltext

A phase I trial of dabrafenib (BRAF inhibitor) and pazopanib in BRAF- mutated advanced malignancies von Haraldsdottir, Sigurdis, Janku, Filip, Timmers, Cynthia Dawn, Geyer, Susan Michelle, Schaaf, Larry J., Sexton, Jennifer L., Thurmond, Jennifer, Velez Bravo, Vivianne Marie, Stepanek, Vanda M. T., Bertino, Erin Marie, Kendra, Kari Lynn, Mortazavi, Amir, Subbiah, Vivek, Poi, Ming, Phelps, Mitch A., Shah, Manisha H.

Volltext

A phase I study of lirilumab (BMS-986015), an anti-KIR monoclonal antibody, administered in combination with ipilimumab, an anti-CTLA4 monoclonal antibody, in patients (Pts) with s... von Rizvi, Naiyer A., Infante, Jeffrey R., Gibney, Geoffrey Thomas, Bertino, Erin Marie, Cooley, Sarah A., Lekatis, Kiki, Wigginton, Jon M., Gutierrez, Andres A., Gupta, Ashok Kumar, Kim, Su Young, Hodi, F. Stephen

Volltext

Multiarm, nonrandomized, open-label phase IB study to evaluate FP1039/GSK3052230 with chemotherapy in NSCLC and MPM with deregulated FGF pathway signaling von Garrido Lopez, Pilar, Felip, Enriqueta, Delord, Jean-Pierre, Paz-Ares, Luis, Grilley-Olson, Juneko E., Gordon, Michael S., Barlesi, Fabrice, Arkenau, Hendrik-Tobias, Lara, Primo, Paik, Paul K., Morgensztern, Daniel, Gadgeel, Shirish M., Reckamp, Karen L., Bertino, Erin Marie, Orlov, Sergey, Levchenko, Eugeny, Delgado, Ignacio, Trigo Perez, Jose Manuel, Moran, Teresa, Lassen, Ulrik Niels

Volltext

A Randomized Double-Blind Phase II Study of the Seneca Valley Virus (NTX-010) versus Placebo for Patients with Extensive-Stage SCLC (ES SCLC) Who Were Stable or Responding after at... von Schenk, Erin L., Mandrekar, Sumithra J., Dy, Grace K., Aubry, Marie Christine, Tan, Angelina D., Dakhil, Shaker R., Sachs, Bradley A., Nieva, Jorge J., Bertino, Erin, Lee Hann, Christine, Schild, Steven E., Wadsworth, Troy W., Adjei, Alex A., Molina, Julian R.

Volltext

A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at lea... von Schenk, Erin L., Mandrekar, Sumithra J., Dy, Grace K., Aubry, Marie Christine, Tan, Angelina D., Dakhil, Shaker R., Sachs, Bradley A., Nieva, Jorge J., Bertino, Erin, Hann, Christine Lee, Schild, Steven E., Wadsworth, Troy W., Adjei, Alex A., Molina, Julian R.

Volltext